Industry News
Biotechnology Industry News
AstraZeneca kicks off work on 1,500-person R&D center in Kendall Square
AstraZeneca kicks off work on 1,500-person R&D center in Kendall Square ntaylor Fri, 04/29/2022 - 04:54
‘Serious missteps’: All Blue makes case for $773M Zymeworks buyout in wake of flagging stock
‘Serious missteps’: All Blue makes case for $773M Zymeworks buyout in wake of flagging stock ntaylor Fri, 04/29/2022 - 03:54
Chutes & Ladders—Merck loses another top exec, this time to Moderna
Chutes & Ladders—Merck loses another top exec, this time to Moderna mbayer Thu, 04/28/2022 - 17:33
Researchers take heart from mRNA’s potential to boost recovery from cardiac attack
Researchers take heart from mRNA's potential to boost recovery from cardiac attack gmasson Thu, 04/28/2022 - 15:29
With the makings of a hub, NYC primed to be life sciences leader
With the makings of a hub, NYC primed to be life sciences leader mwen Thu, 04/28/2022 - 12:48
Sanofi moves patients out of Ukraine warzone in ‘Herculean effort’ to preserve MS trials
Sanofi moves patients out of Ukraine warzone in 'Herculean effort' to preserve MS trials jwaldron Thu, 04/28/2022 - 12:46
UPDATE: Sio Gene Therapies warns of ‘significant’ layoffs after ditching final two assets
UPDATE: Sio Gene Therapies warns of 'significant' layoffs after ditching final two assets mbayer Thu, 04/28/2022 - 10:21
UPDATE: Sio Gene Therapies warns of ‘significant’ layoffs after ditching final 2 assets
UPDATE: Sio Gene Therapies warns of 'significant' layoffs after ditching final 2 assets mbayer Thu, 04/28/2022 - 10:21
Pfizer’s phase 3 DMD gene therapy test resumes after FDA hold, but decision on advanced patients still pending
Pfizer's phase 3 DMD gene therapy test resumes after FDA hold, but decision on advanced patients still pending aarmstrong Thu, 04/28/2022 - 08:55
SURMOUNT-able: Lilly’s tirzepatide clears high bar set by Novo’s Wegovy in obesity
SURMOUNT-able: Lilly's tirzepatide clears high bar set by Novo's Wegovy in obesity ntaylor Thu, 04/28/2022 - 05:31
GV, Sanofi drive British biotech OMass to $100M series B, fueling work on undruggable targets
GV, Sanofi drive British biotech OMass to $100M series B, fueling work on undruggable targets ntaylor Thu, 04/28/2022 - 01:33
Lipids that wind down inflammation could be a critical therapeutic tool for MS
Lipids that wind down inflammation could be a critical therapeutic tool for MS mbayer Wed, 04/27/2022 - 19:05
After Amgen deal, Plexium maintains momentum with AbbVie neurological partnership
After Amgen deal, Plexium maintains momentum with AbbVie neurological partnership gmasson Wed, 04/27/2022 - 16:47
Future shaky at Solid Bio as it shaves off 35% of workforce, chief operating officer plans exit
Future shaky at Solid Bio as it shaves off 35% of workforce, chief operating officer plans exit gmasson Wed, 04/27/2022 - 10:47
BridgeBio strategy head departs amid company’s second round of layoffs this year
BridgeBio strategy head departs amid company’s second round of layoffs this year mbayer Wed, 04/27/2022 - 10:39
BridgeBio strategy head departs amid company’s 2nd round of layoffs this year
BridgeBio strategy head departs amid company's 2nd round of layoffs this year mbayer Wed, 04/27/2022 - 10:39
2 become 1: Caladrius and Cend merge into tumor-focused Lisata Therapeutics
2 become 1: Caladrius and Cend merge into tumor-focused Lisata Therapeutics jwaldron Wed, 04/27/2022 - 09:41
Cytovia inks SPAC merger to get natural killer cells prospects into the clinic
Cytovia inks SPAC merger to get natural killer cells prospects into the clinic ntaylor Wed, 04/27/2022 - 09:21
Spying synthetic lethal promise, Pfizer bets $25M on Zentalis, will support cancer trials
Spying synthetic lethal promise, Pfizer bets $25M on Zentalis, will support cancer trials ntaylor Wed, 04/27/2022 - 07:46
Zolgensma for dementia? AviadoBio gains orphan tag for one-dose gene therapy
Zolgensma for dementia? AviadoBio gains orphan tag for one-dose gene therapy jwaldron Wed, 04/27/2022 - 07:12